Bio-key International, Inc. (NASDAQ: BKYI) reported Q3 EPS of ($0.29), $0.13 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $1.37 million versus the consensus estimate of $2.4 million.

For earnings history and earnings-related data on Bio-key International, Inc. (BKYI) click here.